• ドライアイ患者の治療ニーズに関する webアンケート調査

    髙見大介＊1、木 藤 学 志＊1、多 鹿 哲 也＊1、内 野 美 樹＊2

    ＊1 千寿製薬株式会社 研究開発本部 メディカルアフェアーズ部 ＊2 ケイシン五反田アイクリニック

    医学と薬学, 83(1) 1-11, 2026

  • Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease

    Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2

    1: Senju Pharmaceutical Co., Ltd, Hyogo, Japan. 2: Baylor College of Medicine, Houston, Texas, USA

    American Journal of Ophthalmology. 2026:284:216-225.

    VIEW PUBLICATION　

  • Comprehensive genotoxicity and carcinogenicity evaluations of motugivatrep (SJP-0132) — a transient receptor potential cation channel subfamily V member 1 antagonist

    Kotaro Yamada1, Yoshinori Yamagiwa1, Hideya Yonekura1, Satoko Doi1, Mana Okada1, Satomi Kikuchi2, Yoshihisa Nakano2, Shigeki Matsumoto2, Gen Suzuki1, Ikuyo Atsumi1

    1: Central Research Laboratories, Senju Pharmaceutical Co., Ltd. 2: Drug Discovery Research Center, Mochida Pharmaceutical Co., Ltd.

    Fundamental Toxicological Sciences. 2026, 13: 103-117.

    VIEW PUBLICATION　

  • アジマイシン点眼液1％の抗菌活性の経年的推移に関する特定使用成績調査

    鳥山浩二1)　水田藍2)　坂本祐一郎2)　末信敏秀2)　井上幸次3)

    1) 愛媛大学医学部眼科学教室　2)千寿製薬株式会社　3)日野病院

    あたらしい眼科42(12)：1566～1576

  • Efficacy and Safety of SJP-0132 in Patients with Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study

    Yuichi Hori1, Tomoyuki Wada2, Kazunori Omatsu2, on behalf of the SJP-0132 clinical study investigators

    1: Department of Ophthalmology, Toho University Faculty of Medicine, Tokyo, Japan. 2: Senju Pharmaceutical Co., Ltd, Hyogo, Japan.

    American Journal of Ophthalmology. 2026;283:163-175.

    VIEW PUBLICATION　

  • Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Perspectives in Japan

    Yasuo Yanagi1, Kanji Takahashi2, Tomohiro Iida3, Fumi Gomi4, Hiroshi Onishi5, Junko Morii6, Taiji Sakamoto7

    1 Department of Ophthalmology and Micro‑technology, Yokohama City University, Yokohama, Kanagawa, Japan

    2 Department of Ophthalmology, Kansai Medical University, Osaka, Japan

    3 Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan

    4 Department of Ophthalmology, Hyogo Medical University, Nishinomiya, Hyogo, Japan

    5 Senju Pharmaceutical Co., Ltd., Osaka, Japan

    6 IQVIA Solutions Japan G.K., Tokyo, Japan

    7 Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

    Ophthalmology and Therapy. 2024 Oct;13(10):2629-2644.

  • Identification of meibomian gland testosterone metabolites produced by tissue-intrinsic intracrine deactivation activity

    Khanh Tien Nguyen Pham 1, Takahito Miyake 1, Tomo Suzuki 2,3, Shigeru Kinoshita4, Yuki Hamada 1, Hikari Uehara 1, Mamiko Machida 5, Takeshi Nakajima 5, Emi Hasegawa1, and Masao Doi 1,

    1 Department of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan

    2 Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-0841, Japan

    3 Department of Ophthalmology, Kyoto City Hospital, Nakagyo-ku, Kyoto 604-8845, Japan

    4 Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-0841, Japan

    5 Senju Laboratory of Ocular Sciences, Senju Pharmaceutical Co., Ltd., Kobe 650-0047, Japan

    iScience 28, 111808, February 21, 2025

  • Effects of dihydrocapsiateonsalivary secretion in healthy subjects:A randomized, double-blind, placebo-controlled, crossover study

    Keisuke Yoshida1, Ryuji Takeda2, and Osamu Sakai1.

    1 Senju Pharmaceutical, Co., Ltd.,

    2 Kansai University of Welfare Sciences

    Functional Foods in Health and Disease2025; 15(6): 359 -368

  • 細菌性外眼部感染症分離株の抗菌薬に対する感受性動向（2019，2023年の比較）

    秦野　寛1、水田　藍2　坂本　祐一郎2　末信　敏秀2

    1 ルミネはたの眼科

    2 千寿製薬株式会社　信頼性保証本部　医薬情報企画部

    臨床眼科79（3）:346-354,2025

  • 特集　各動物種における網膜電図検査法とその評価：ウサギにおける網膜電図検査法（非臨床安全性研究）

    政次 美紀、厚見 育代

    比較眼科研究, 2024;43:16-20

See more